BioSpace News Archive

Pharm Country

Synergy Pharmaceuticals Presents Results From Study Examining Patient And Physician Perceptions And Experiences With Irritable Bowel Syndrome With Constipation (IBS-C)

Synergy Pharma announced today new findings highlighting the frustration of patients suffering from irritable bowel syndrome with constipation (IBS-C) and the perceptions of healthcare providers (HCPs) who treat these patients.

October 17, 2017

·

6 min read

BioMidwest

Chicago’s Attune Medical Scores $10M Series C

The cash will support continued global adoption of its esophageal temperature management device.

October 17, 2017

·

4 min read

Drug Development

M3 Biotechnology Launches Clinical Trials For Alzheimer’s Disease Drug Focused On Restoring Lost Connections In The Brain

A six-year-old biotech company at the leading edge of regenerative medicine is bringing a therapy for Alzheimer’s to Phase I clinical trials that is expected to slow or stop disease progression as indicated by pre-clinical studies, announced M3 CEO Leen Kawas.

October 17, 2017

·

2 min read

Business

Cleveland Clinic Joins PierianDx’s Customer Network To Accelerate Precision Medicine

PierianDx announced today that Cleveland Clinic will utilize its integrated “one space” workflow and analysis solution, Clinical Genomicist Workspace (CGW), to advance precision medicine for patients.

October 17, 2017

·

1 min read

Bio NC

Significant Advance in Breast Cancer Care – Cohera Medical Drain-Free Mastectomy Trial Reaches Full Enrollment

11 breast centers in the UK and Germany complete enrollment of a clinical study comparing mastectomy flap closure using TissuGlu without surgical drains vs. standard of care with drain.

October 17, 2017

·

4 min read

Drug Development

Immuron Highlights Market Opportunity Following Recent Studies on Antibiotic Correlation to C. Difficile Infections

One study performed by the Minnesota Department of Health on antibiotic prescribing for dental procedures in community-associated clostridium difficile cases, which was presented at ID Week 2017.

October 17, 2017

·

6 min read

Business

Clinipace Worldwide Co-Founder and CEO Jeff Williams to Resign as CEO

Will focus on board-level issues while Jason Monteleone takes over the reins.

October 17, 2017

·

2 min read

Ablynx Announces Launch Of Proposed Global Offering

Ablynx intends to offer and sell, subject to market and other conditions, approximately $175 million of its ordinary shares in a global offering.

October 17, 2017

·

6 min read

Drug Development

ProMIS Neurosciences Lead Product Candidate, PMN310, Shows Desired Target Binding Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies for Alzheimer’s Disease

Narrated presentation of results available on ProMIS website

October 17, 2017

·

4 min read

Drug Development

Incysus Announces FDA Approval of IND Application for a Phase 1 Study of a Gamma-Delta (γδ) T Cell Leukemia and Lymphoma Immunotherapy

Incysus Announces FDA Approval of IND Application for a Phase I Study of a Gamma-Delta T Cell Leukemia and Lymphoma Immunotherapy

October 17, 2017

·

2 min read